Controlled Substances: 2015 Established Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids, 34695 [2015-14909]

Download as PDF 34695 Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices Dated: June 11, 2015. Chuck Rosenberg, Acting Administrator. Background [FR Doc. 2015–14910 Filed 6–16–15; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–410F] Controlled Substances: 2015 Established Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids Drug Enforcement Administration, Department of Justice. ACTION: Final order. AGENCY: This final order establishes the initial 2015 aggregate production quotas for three temporarily controlled synthetic cannabinoids: N-(1-amino-3methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide (AB-CHMINACA), N-(1amino-3-methyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3-carboxamide (ABPINACA), and [1-(5-fluoropentyl)-1Hindazol-3-yl](naphthalen-1yl)methanone (THJ-2201). DATES: Effective June 17, 2015. FOR FURTHER INFORMATION CONTACT: John R. Scherbenske, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. SUPPLEMENTARY INFORMATION: SUMMARY: Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) requires the Attorney General to establish aggregate production quotas for each basic class of controlled substance listed in schedules I and II and for ephedrine, pseudoephedrine, and phenylpropanolamine. The Attorney General has delegated this authority to the Administrator of the DEA. 28 CFR 0.100(b). On January 30, 2015, the DEA published in the Federal Register a final order to temporarily place three synthetic cannabinoids, N-(1-amino-3methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide (AB-CHMINACA), N-(1amino-3-methyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3-carboxamide (ABPINACA), and [1-(5-fluoropentyl)-1Hindazol-3-yl](naphthalen-1yl)methanone (THJ-2201), into schedule I of the CSA (80 FR 5042), making all regulatory controls pertaining to schedule I controlled substances applicable to AB-CHMINACA, ABPINACA, and THJ-2201, including the requirement to obtain a manufacturing quota pursuant to 21 CFR part 1303. The 2015 aggregate production quotas for AB-CHMINACA, AB-PINACA, and THJ-2201 represent those quantities that may be manufactured in the United States in 2015 to provide for the estimated scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. On March 20, 2015, the DEA published a notice titled, ‘‘Controlled Substances: 2015 Proposed Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids’’ in the Federal Register (80 FR 15034). That notice proposed the 2015 aggregate production quotas for AB-CHMINACA, AB-PINACA, and THJ2201. Interested persons were invited to comment on or object to the proposed aggregate production quotas for ABCHMINACA, AB-PINACA, and THJ2201 on or before April 20, 2015. No comments were received. Analysis for 2015 Established Aggregate Production Quotas In determining the 2015 aggregate production quotas for N-(1-amino-3methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3carboxamide (AB-CHMINACA), N-(1amino-3-methyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3-carboxamide (ABPINACA), and [1-(5-fluoropentyl)-1Hindazol-3-yl](naphthalen-1yl)methanone (THJ-2201), the DEA has taken into consideration the factors set forth at 21 CFR 1303.11, pursuant to 21 U.S.C. 826(a), and other relevant factors, including 2015 export requirements, industrial use, applications for quotas, as well as information on research and product development requirements. Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11, the Acting Administrator hereby establishes the 2015 aggregate production quotas for AB-CHMINACA, AB-PINACA, and THJ2201, expressed in grams of anhydrous acid or base, as follows: Established 2015 quota (g) Basic class—schedule I N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) ................................. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) .......................................................... [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) .................................................................................. asabaliauskas on DSK5VPTVN1PROD with NOTICES In accordance with 21 CFR 1303.13, upon consideration of the relevant factors, the Acting Administrator may adjust the 2015 aggregate production quotas for AB-CHMINACA, ABPINACA, and THJ-2201 as needed. Dated: June 11, 2015. Chuck Rosenberg, Acting Administrator. [FR Doc. 2015–14909 Filed 6–16–15; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 18:47 Jun 16, 2015 Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration: Mylan Technologies, Inc. ACTION: Jkt 235001 Notice of registration. Mylan Technologies, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Mylan Technologies, Inc. registration as an importer of those controlled substances. SUMMARY: PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 By notice dated February 11, 2015, and published in the Federal Register on February 19, 2015, 80 FR 8902, Mylan Technologies, Inc., 110 Lake Street, Saint Albans, Vermont 05478 applied to be registered as an importer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Mylan Technologies, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE 15 15 15 E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 80, Number 116 (Wednesday, June 17, 2015)]
[Notices]
[Page 34695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14909]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-410F]


Controlled Substances: 2015 Established Aggregate Production 
Quotas for Three Temporarily Controlled Synthetic Cannabinoids

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Final order.

-----------------------------------------------------------------------

SUMMARY: This final order establishes the initial 2015 aggregate 
production quotas for three temporarily controlled synthetic 
cannabinoids: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N-(1-amino-
3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-
PINACA), and [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-
yl)methanone (THJ-2201).

DATES: Effective June 17, 2015.

FOR FURTHER INFORMATION CONTACT: John R. Scherbenske, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812.

SUPPLEMENTARY INFORMATION:

Background

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for each basic class of controlled substance listed in schedules I and 
II and for ephedrine, pseudoephedrine, and phenylpropanolamine. The 
Attorney General has delegated this authority to the Administrator of 
the DEA. 28 CFR 0.100(b).
    On January 30, 2015, the DEA published in the Federal Register a 
final order to temporarily place three synthetic cannabinoids, N-(1-
amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide (AB-CHMINACA), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide (AB-PINACA), and [1-(5-fluoropentyl)-
1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201), into schedule I 
of the CSA (80 FR 5042), making all regulatory controls pertaining to 
schedule I controlled substances applicable to AB-CHMINACA, AB-PINACA, 
and THJ-2201, including the requirement to obtain a manufacturing quota 
pursuant to 21 CFR part 1303.
    The 2015 aggregate production quotas for AB-CHMINACA, AB-PINACA, 
and THJ-2201 represent those quantities that may be manufactured in the 
United States in 2015 to provide for the estimated scientific, 
research, and industrial needs of the United States, lawful export 
requirements, and the establishment and maintenance of reserve stocks.
    On March 20, 2015, the DEA published a notice titled, ``Controlled 
Substances: 2015 Proposed Aggregate Production Quotas for Three 
Temporarily Controlled Synthetic Cannabinoids'' in the Federal Register 
(80 FR 15034). That notice proposed the 2015 aggregate production 
quotas for AB-CHMINACA, AB-PINACA, and THJ-2201. Interested persons 
were invited to comment on or object to the proposed aggregate 
production quotas for AB-CHMINACA, AB-PINACA, and THJ-2201 on or before 
April 20, 2015. No comments were received.

Analysis for 2015 Established Aggregate Production Quotas

    In determining the 2015 aggregate production quotas for N-(1-amino-
3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide (AB-CHMINACA), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide (AB-PINACA), and [1-(5-fluoropentyl)-
1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201), the DEA has 
taken into consideration the factors set forth at 21 CFR 1303.11, 
pursuant to 21 U.S.C. 826(a), and other relevant factors, including 
2015 export requirements, industrial use, applications for quotas, as 
well as information on research and product development requirements.
    Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11, 
the Acting Administrator hereby establishes the 2015 aggregate 
production quotas for AB-CHMINACA, AB-PINACA, and THJ-2201, expressed 
in grams of anhydrous acid or base, as follows:

------------------------------------------------------------------------
                                                          Established
                Basic class--schedule I                 2015 quota (g)
-----------------------------------------------------------------------
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-                             15
 (cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-
 CHMINACA)............................................
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-                   15
 indazole-3-carboxamide (AB-PINACA)...................
[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-                  15
 yl)methanone (THJ-2201)..............................
------------------------------------------------------------------------

    In accordance with 21 CFR 1303.13, upon consideration of the 
relevant factors, the Acting Administrator may adjust the 2015 
aggregate production quotas for AB-CHMINACA, AB-PINACA, and THJ-2201 as 
needed.

    Dated: June 11, 2015.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2015-14909 Filed 6-16-15; 8:45 am]
 BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.